Glaxo to Pay $3B to Settle U.S. Sales Cases

Glaxo to Pay $3B to Settle U.S. Sales Cases

Asim Hafeez/Bloomberg

The potential settlement brings Glaxo closer to putting years of legal probes behind it. The company set aside 2.2 billion pounds ($3.5 billion) in the fourth quarter in anticipation of reaching an agreement on the cases.